Recurrent Ischemic Stroke: Strategies for Prevention
- PMID: 29094912
Recurrent Ischemic Stroke: Strategies for Prevention
Abstract
Recurrent strokes make up almost 25% of the nearly 800,000 strokes that occur annually in the United States. Risk factors for ischemic stroke include hypertension, diabetes mellitus, hyperlipidemia, sleep apnea, and obesity. Lifestyle modifications, including tobacco cessation, decreased alcohol use, and increased physical activity, are also important in the management of patients with a history of stroke or transient ischemic attack. Antiplatelet therapy is recommended to reduce the risk of recurrent ischemic stroke. The selection of antiplatelet therapy should be based on timing, safety, effectiveness, cost, patient characteristics, and patient preference. Aspirin is recommended as initial treatment to prevent recurrent ischemic stroke. Clopidogrel is recommended as an alternative monotherapy and in patients allergic to aspirin. The combination of clopidogrel and aspirin is not recommended for long-term use (more than two to three years) because of increased bleeding risk. Aspirin/dipyridamole is at least as effective as aspirin alone, but it is not as well tolerated. Warfarin should not be used for prevention of recurrent ischemic stroke.
Similar articles
-
Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.Postgrad Med. 2010 Mar;122(2):49-53. doi: 10.3810/pgm.2010.03.2121. Postgrad Med. 2010. PMID: 20203455 Review.
-
Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.Cerebrovasc Dis. 2015;39(1):13-22. doi: 10.1159/000369778. Epub 2014 Dec 24. Cerebrovasc Dis. 2015. PMID: 25547900 Review.
-
Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.Curr Cardiol Rep. 2015 Oct;17(10):89. doi: 10.1007/s11886-015-0642-4. Curr Cardiol Rep. 2015. PMID: 26294261 Review.
-
Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.Stroke. 2017 Sep;48(9):2610-2613. doi: 10.1161/STROKEAHA.117.017895. Epub 2017 Jul 12. Stroke. 2017. PMID: 28701574 Review.
-
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.Stroke. 2021 Oct;52(10):3258-3265. doi: 10.1161/STROKEAHA.120.031755. Epub 2021 Jul 26. Stroke. 2021. PMID: 34304604 Free PMC article.
Cited by
-
Effectiveness of an institution-based adapted physical activity programme versus a home-based self-management programme for chronic poststroke adults: protocol for a randomised controlled study.BMJ Open. 2024 Jul 20;14(7):e084688. doi: 10.1136/bmjopen-2024-084688. BMJ Open. 2024. PMID: 39032927 Free PMC article.
-
Peripheral vascular function in stroke: systematic review and meta-analysis.J Appl Physiol (1985). 2024 May 1;136(5):1182-1194. doi: 10.1152/japplphysiol.00601.2023. Epub 2024 Mar 14. J Appl Physiol (1985). 2024. PMID: 38482571
-
Association of short-term hospital-level outcome metrics with 1-year mortality and recurrence for US Medicare beneficiaries with ischemic stroke.PLoS One. 2023 Aug 10;18(8):e0289790. doi: 10.1371/journal.pone.0289790. eCollection 2023. PLoS One. 2023. PMID: 37561680 Free PMC article.
-
Development of a Readiness for Hospital Discharge assessment tool in Thai patients with stroke.Belitung Nurs J. 2022 Feb 22;8(1):75-83. doi: 10.33546/bnj.1968. eCollection 2022. Belitung Nurs J. 2022. PMID: 37521078 Free PMC article.
-
Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration.Ophthalmol Ther. 2023 Oct;12(5):2583-2608. doi: 10.1007/s40123-023-00742-9. Epub 2023 Jul 10. Ophthalmol Ther. 2023. PMID: 37430077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
